Search Results 1511-1520 of 19479 for Myocardium

1. Durvalumab and Grid Therapy for the Treatment of Non-small Cell Lung Cancer in Patients Who Progressed During or After Treatment With the PACIFIC Regimen - Mayo Clinic

   History of myocardial infarction ≤ 6 months, or congestive heart failure requiring use of ongoing maintenance therapy for life-threatening ventricular ...

2. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

   Participation eligibility · Acute myocardial infarction, acute coronary syndrome or coronary revascularization within 90 days prior to Screening. · Stroke or TIA ...

3. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Unstable angina, myocardial infarction, coronary artery bypass graft (CABG), or stroke within 6 months prior to screening;; Left ventricle ejection fraction ...

4. Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients - Mayo Clinic

   Evidence of non-catheter related deep vein thrombosis, stroke, myocardial infarction, or arterial embolus within the 3 months before the Day 1 Visit ...

5. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

   No history of myocardial infarction, severe or unstable angina, clinically significant peripheral vascular disease, ≥ grade 2 heart failure, or serious and ...

6. Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

   Myocardial infarction within 6 months prior to enrollment, or has New York Heart Association (NYHA) class III or IV heart failure, uncontrolled angina ...

7. RAPA-501 Therapy for ALS Expanded Access Protocol - Mayo Clinic

   Clinically significant cardiac pathology, as defined by: myocardial infarction within 6 months prior to enrollment, Class III or IV heart failure according ...

8. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

   Ischemia or myocardial infarct within 1 year prior to the Screening Visit;; Clinically significant atrial or ventricular dysrhythmia; the heart must be in ...

9. A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus - Mayo Clinic

   Known history of clinically significant cardiovascular (e.g., history of myocardial infarction, congestive heart failure or uncontrolled hypertension > 90 ...

10. Publications - Harry E. Fuentes Bayne, M.D., M.S. - Mayo Clinic

    ... myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013. Vasc Med. 2019 Aug; 24 (4):341-348 Epub 2019 Mar 27. View PubMed ...